Codexis, Inc.
$1.36
$0.04 (+3.03%)
$1.31Day Range$1.40
Key Statistics
Market Cap
$148.93M
Shares Outstanding
109.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 22, 2010
Round Lot
100
Locale
US
Trading Data
Day Open
$1.32
Day High
$1.40
Day Low
$1.31
Volume
2.88M
VWAP
$1.36
Prev Close
$1.32
Transactions
--
Acc. Volume
--
About Codexis, Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
INDUSTRIAL ORGANIC CHEMICALSSIC 2860146 employees200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063650-421-8100IPO Apr 22, 2010US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001200375
- Composite FIGI
- BBG000RN0GZ5
- Share Class FIGI
- BBG001SV4129
- Ticker Root
- CDXS
- SIC Code
- 2860
About Codexis, Inc. (CDXS) Stock
Codexis, Inc. (CDXS) closed the 2026-09-18 session at $1.36, up 3.03% versus the previous close (+0.04). The stock opened at $1.32 and traded between $1.31 and $1.40 during that session. Session trading volume was 2.9M shares. The volume-weighted average price (VWAP) is $1.36.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Codexis, Inc. has a market capitalization of $148.9 million. The company operates in the INDUSTRIAL ORGANIC CHEMICALS industry classification. CDXS is listed on the XNAS exchange. The company employs approximately 146 people. Codexis, Inc. is headquartered in REDWOOD CITY, CA. The recorded listing date is 2010-04-22.
On this page you can find market CDXS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the INDUSTRIAL ORGANIC CHEMICALS sector.